Loading…
Fast and sensitive analysis of dermorphin and HYP6-dermorphin in equine plasma using liquid chromatography tandem mass spectrometry
Dermorphin and HYP6‐dermorphin are hepta‐peptides and natural opioids originally isolated from the skin of South American frogs. They are more potent than morphine but less likely to produce drug tolerance and addiction. These properties make them ideal candidates for the doping of racehorses to enh...
Saved in:
Published in: | Drug testing and analysis 2014-04, Vol.6 (4), p.342-349 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 349 |
container_issue | 4 |
container_start_page | 342 |
container_title | Drug testing and analysis |
container_volume | 6 |
creator | Wang, Caroline C. Hartmann-Fischbach, Petra Krueger, Tim R. Wells, Terry L. Feineman, Amy R. Compton, Joanne C. |
description | Dermorphin and HYP6‐dermorphin are hepta‐peptides and natural opioids originally isolated from the skin of South American frogs. They are more potent than morphine but less likely to produce drug tolerance and addiction. These properties make them ideal candidates for the doping of racehorses to enhance performance during competition. Dermorphin was recently classified as a Class I drug by Racing Commissioners International (RCI), indicating that it is a banned substance in equine athletes. To enforce this ban, a fast and sensitive method was developed for dermorphin and HYP6‐dermorphin analysis in equine plasma. Equine plasma (2 ml) was extracted on a mixed mode cation exchange solid‐phase column. After extraction, dermorphin and HYP6‐dermorphin were separated and detected using a liquid chromatography (LC) triple quadrupole linear ion trap mass spectrometry in positive multiple‐reaction‐monitoring (MRM) mode. Each analysis was 3.5 min. Four MRM transitions were used for identification of each compound. The extraction procedure was efficient and the limits of detection (LOD) were 2 pg/ml and 10 pg/ml for dermorphin and HYP6‐dermorphin, respectively. The method has good selectivity and precision. Results of stability studies showed that both analytes were stable at low temperature. This is the first report of dermorphin and HYP6‐dermorphin analysis in equine plasma, which could be adopted as a regular screening or confirmation method for controlling the abuse of these compounds in equine sports. Copyright © 2013 John Wiley & Sons, Ltd.
Dermorphin and HYP6‐dermorphin are potent hepta‐peptides used in horse racing to enhance performance. We developed a method for dermorphin and HYP6‐dermorphin analysis in equine plasma. This method is fast, sensitive, and reliable, which could be adopted as a regular screening or confirmation method for controlling the abuse of these compounds in equine sports. |
doi_str_mv | 10.1002/dta.1487 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1515642785</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1515642785</sourcerecordid><originalsourceid>FETCH-LOGICAL-i2457-75d5bdf971e7bf047cf150d39543b323d3a9a4a51479f08f0e9bf832a70b75ec3</originalsourceid><addsrcrecordid>eNpdkVtPFTEUhRuikYsm_gLTxBdfBnudzjxyEY6EoDEo-tR0pns4hbnRdoB59o_TA3g0JjvZty_rYS2E3lKySwlhH200u1QUagNt0VKwTOWUvljPhG-i7RCuCMkF4_IV2mRcMcKY2EK_j0yI2PQWB-iDi-4W0mbaObiAhwZb8N3gx6XrH6HFr6959s8tFdxMrgc8tiZ0Bk_B9Ze4delocb30Q2ficOnNuJxxTArQ4c6EgMMIdUxfiH5-jV42pg3w5rnvoO9Hn84PFtnpl-PPB3unmWNCqkxJKyvblIqCqhoiVN1QSSwvpeAVZ9xyUxphJBWqbEjRECirpuDMKFIpCTXfQR-edEc_3EwQou5cqKFtTQ_DFDSVVCaHVCET-v4_9GqYfPLlkRKkFLkoEvXumZqqDqweveuMn_UfexOQPQF3roV5_adEr2LTKTa9ik0fnu-t-l_ehQj3a974a50rrqS-ODvWP85-Fvxk_5te8Aer-5o-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1514094648</pqid></control><display><type>article</type><title>Fast and sensitive analysis of dermorphin and HYP6-dermorphin in equine plasma using liquid chromatography tandem mass spectrometry</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Wang, Caroline C. ; Hartmann-Fischbach, Petra ; Krueger, Tim R. ; Wells, Terry L. ; Feineman, Amy R. ; Compton, Joanne C.</creator><creatorcontrib>Wang, Caroline C. ; Hartmann-Fischbach, Petra ; Krueger, Tim R. ; Wells, Terry L. ; Feineman, Amy R. ; Compton, Joanne C.</creatorcontrib><description>Dermorphin and HYP6‐dermorphin are hepta‐peptides and natural opioids originally isolated from the skin of South American frogs. They are more potent than morphine but less likely to produce drug tolerance and addiction. These properties make them ideal candidates for the doping of racehorses to enhance performance during competition. Dermorphin was recently classified as a Class I drug by Racing Commissioners International (RCI), indicating that it is a banned substance in equine athletes. To enforce this ban, a fast and sensitive method was developed for dermorphin and HYP6‐dermorphin analysis in equine plasma. Equine plasma (2 ml) was extracted on a mixed mode cation exchange solid‐phase column. After extraction, dermorphin and HYP6‐dermorphin were separated and detected using a liquid chromatography (LC) triple quadrupole linear ion trap mass spectrometry in positive multiple‐reaction‐monitoring (MRM) mode. Each analysis was 3.5 min. Four MRM transitions were used for identification of each compound. The extraction procedure was efficient and the limits of detection (LOD) were 2 pg/ml and 10 pg/ml for dermorphin and HYP6‐dermorphin, respectively. The method has good selectivity and precision. Results of stability studies showed that both analytes were stable at low temperature. This is the first report of dermorphin and HYP6‐dermorphin analysis in equine plasma, which could be adopted as a regular screening or confirmation method for controlling the abuse of these compounds in equine sports. Copyright © 2013 John Wiley & Sons, Ltd.
Dermorphin and HYP6‐dermorphin are potent hepta‐peptides used in horse racing to enhance performance. We developed a method for dermorphin and HYP6‐dermorphin analysis in equine plasma. This method is fast, sensitive, and reliable, which could be adopted as a regular screening or confirmation method for controlling the abuse of these compounds in equine sports.</description><identifier>ISSN: 1942-7603</identifier><identifier>EISSN: 1942-7611</identifier><identifier>DOI: 10.1002/dta.1487</identifier><identifier>PMID: 23720224</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Animals ; Chromatography, High Pressure Liquid - economics ; Chromatography, High Pressure Liquid - methods ; dermorphin ; Doping in Sports ; equine plasma ; Horses - blood ; HYP6-dermorphin ; Limit of Detection ; liquid chromatography ; mass spectrometry ; Opioid Peptides - blood ; Opioid Peptides - isolation & purification ; Solid Phase Extraction ; Tandem Mass Spectrometry - economics ; Tandem Mass Spectrometry - methods</subject><ispartof>Drug testing and analysis, 2014-04, Vol.6 (4), p.342-349</ispartof><rights>Copyright © 2013 John Wiley & Sons, Ltd.</rights><rights>Copyright © 2014 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23720224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Caroline C.</creatorcontrib><creatorcontrib>Hartmann-Fischbach, Petra</creatorcontrib><creatorcontrib>Krueger, Tim R.</creatorcontrib><creatorcontrib>Wells, Terry L.</creatorcontrib><creatorcontrib>Feineman, Amy R.</creatorcontrib><creatorcontrib>Compton, Joanne C.</creatorcontrib><title>Fast and sensitive analysis of dermorphin and HYP6-dermorphin in equine plasma using liquid chromatography tandem mass spectrometry</title><title>Drug testing and analysis</title><addtitle>Drug Test. Analysis</addtitle><description>Dermorphin and HYP6‐dermorphin are hepta‐peptides and natural opioids originally isolated from the skin of South American frogs. They are more potent than morphine but less likely to produce drug tolerance and addiction. These properties make them ideal candidates for the doping of racehorses to enhance performance during competition. Dermorphin was recently classified as a Class I drug by Racing Commissioners International (RCI), indicating that it is a banned substance in equine athletes. To enforce this ban, a fast and sensitive method was developed for dermorphin and HYP6‐dermorphin analysis in equine plasma. Equine plasma (2 ml) was extracted on a mixed mode cation exchange solid‐phase column. After extraction, dermorphin and HYP6‐dermorphin were separated and detected using a liquid chromatography (LC) triple quadrupole linear ion trap mass spectrometry in positive multiple‐reaction‐monitoring (MRM) mode. Each analysis was 3.5 min. Four MRM transitions were used for identification of each compound. The extraction procedure was efficient and the limits of detection (LOD) were 2 pg/ml and 10 pg/ml for dermorphin and HYP6‐dermorphin, respectively. The method has good selectivity and precision. Results of stability studies showed that both analytes were stable at low temperature. This is the first report of dermorphin and HYP6‐dermorphin analysis in equine plasma, which could be adopted as a regular screening or confirmation method for controlling the abuse of these compounds in equine sports. Copyright © 2013 John Wiley & Sons, Ltd.
Dermorphin and HYP6‐dermorphin are potent hepta‐peptides used in horse racing to enhance performance. We developed a method for dermorphin and HYP6‐dermorphin analysis in equine plasma. This method is fast, sensitive, and reliable, which could be adopted as a regular screening or confirmation method for controlling the abuse of these compounds in equine sports.</description><subject>Animals</subject><subject>Chromatography, High Pressure Liquid - economics</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>dermorphin</subject><subject>Doping in Sports</subject><subject>equine plasma</subject><subject>Horses - blood</subject><subject>HYP6-dermorphin</subject><subject>Limit of Detection</subject><subject>liquid chromatography</subject><subject>mass spectrometry</subject><subject>Opioid Peptides - blood</subject><subject>Opioid Peptides - isolation & purification</subject><subject>Solid Phase Extraction</subject><subject>Tandem Mass Spectrometry - economics</subject><subject>Tandem Mass Spectrometry - methods</subject><issn>1942-7603</issn><issn>1942-7611</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpdkVtPFTEUhRuikYsm_gLTxBdfBnudzjxyEY6EoDEo-tR0pns4hbnRdoB59o_TA3g0JjvZty_rYS2E3lKySwlhH200u1QUagNt0VKwTOWUvljPhG-i7RCuCMkF4_IV2mRcMcKY2EK_j0yI2PQWB-iDi-4W0mbaObiAhwZb8N3gx6XrH6HFr6959s8tFdxMrgc8tiZ0Bk_B9Ze4delocb30Q2ficOnNuJxxTArQ4c6EgMMIdUxfiH5-jV42pg3w5rnvoO9Hn84PFtnpl-PPB3unmWNCqkxJKyvblIqCqhoiVN1QSSwvpeAVZ9xyUxphJBWqbEjRECirpuDMKFIpCTXfQR-edEc_3EwQou5cqKFtTQ_DFDSVVCaHVCET-v4_9GqYfPLlkRKkFLkoEvXumZqqDqweveuMn_UfexOQPQF3roV5_adEr2LTKTa9ik0fnu-t-l_ehQj3a974a50rrqS-ODvWP85-Fvxk_5te8Aer-5o-</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Wang, Caroline C.</creator><creator>Hartmann-Fischbach, Petra</creator><creator>Krueger, Tim R.</creator><creator>Wells, Terry L.</creator><creator>Feineman, Amy R.</creator><creator>Compton, Joanne C.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>Fast and sensitive analysis of dermorphin and HYP6-dermorphin in equine plasma using liquid chromatography tandem mass spectrometry</title><author>Wang, Caroline C. ; Hartmann-Fischbach, Petra ; Krueger, Tim R. ; Wells, Terry L. ; Feineman, Amy R. ; Compton, Joanne C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i2457-75d5bdf971e7bf047cf150d39543b323d3a9a4a51479f08f0e9bf832a70b75ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Chromatography, High Pressure Liquid - economics</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>dermorphin</topic><topic>Doping in Sports</topic><topic>equine plasma</topic><topic>Horses - blood</topic><topic>HYP6-dermorphin</topic><topic>Limit of Detection</topic><topic>liquid chromatography</topic><topic>mass spectrometry</topic><topic>Opioid Peptides - blood</topic><topic>Opioid Peptides - isolation & purification</topic><topic>Solid Phase Extraction</topic><topic>Tandem Mass Spectrometry - economics</topic><topic>Tandem Mass Spectrometry - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Caroline C.</creatorcontrib><creatorcontrib>Hartmann-Fischbach, Petra</creatorcontrib><creatorcontrib>Krueger, Tim R.</creatorcontrib><creatorcontrib>Wells, Terry L.</creatorcontrib><creatorcontrib>Feineman, Amy R.</creatorcontrib><creatorcontrib>Compton, Joanne C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Drug testing and analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Caroline C.</au><au>Hartmann-Fischbach, Petra</au><au>Krueger, Tim R.</au><au>Wells, Terry L.</au><au>Feineman, Amy R.</au><au>Compton, Joanne C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fast and sensitive analysis of dermorphin and HYP6-dermorphin in equine plasma using liquid chromatography tandem mass spectrometry</atitle><jtitle>Drug testing and analysis</jtitle><addtitle>Drug Test. Analysis</addtitle><date>2014-04</date><risdate>2014</risdate><volume>6</volume><issue>4</issue><spage>342</spage><epage>349</epage><pages>342-349</pages><issn>1942-7603</issn><eissn>1942-7611</eissn><abstract>Dermorphin and HYP6‐dermorphin are hepta‐peptides and natural opioids originally isolated from the skin of South American frogs. They are more potent than morphine but less likely to produce drug tolerance and addiction. These properties make them ideal candidates for the doping of racehorses to enhance performance during competition. Dermorphin was recently classified as a Class I drug by Racing Commissioners International (RCI), indicating that it is a banned substance in equine athletes. To enforce this ban, a fast and sensitive method was developed for dermorphin and HYP6‐dermorphin analysis in equine plasma. Equine plasma (2 ml) was extracted on a mixed mode cation exchange solid‐phase column. After extraction, dermorphin and HYP6‐dermorphin were separated and detected using a liquid chromatography (LC) triple quadrupole linear ion trap mass spectrometry in positive multiple‐reaction‐monitoring (MRM) mode. Each analysis was 3.5 min. Four MRM transitions were used for identification of each compound. The extraction procedure was efficient and the limits of detection (LOD) were 2 pg/ml and 10 pg/ml for dermorphin and HYP6‐dermorphin, respectively. The method has good selectivity and precision. Results of stability studies showed that both analytes were stable at low temperature. This is the first report of dermorphin and HYP6‐dermorphin analysis in equine plasma, which could be adopted as a regular screening or confirmation method for controlling the abuse of these compounds in equine sports. Copyright © 2013 John Wiley & Sons, Ltd.
Dermorphin and HYP6‐dermorphin are potent hepta‐peptides used in horse racing to enhance performance. We developed a method for dermorphin and HYP6‐dermorphin analysis in equine plasma. This method is fast, sensitive, and reliable, which could be adopted as a regular screening or confirmation method for controlling the abuse of these compounds in equine sports.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23720224</pmid><doi>10.1002/dta.1487</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1942-7603 |
ispartof | Drug testing and analysis, 2014-04, Vol.6 (4), p.342-349 |
issn | 1942-7603 1942-7611 |
language | eng |
recordid | cdi_proquest_miscellaneous_1515642785 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Animals Chromatography, High Pressure Liquid - economics Chromatography, High Pressure Liquid - methods dermorphin Doping in Sports equine plasma Horses - blood HYP6-dermorphin Limit of Detection liquid chromatography mass spectrometry Opioid Peptides - blood Opioid Peptides - isolation & purification Solid Phase Extraction Tandem Mass Spectrometry - economics Tandem Mass Spectrometry - methods |
title | Fast and sensitive analysis of dermorphin and HYP6-dermorphin in equine plasma using liquid chromatography tandem mass spectrometry |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T16%3A36%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fast%20and%20sensitive%20analysis%20of%20dermorphin%20and%20HYP6-dermorphin%20in%20equine%20plasma%20using%20liquid%20chromatography%20tandem%20mass%20spectrometry&rft.jtitle=Drug%20testing%20and%20analysis&rft.au=Wang,%20Caroline%20C.&rft.date=2014-04&rft.volume=6&rft.issue=4&rft.spage=342&rft.epage=349&rft.pages=342-349&rft.issn=1942-7603&rft.eissn=1942-7611&rft_id=info:doi/10.1002/dta.1487&rft_dat=%3Cproquest_pubme%3E1515642785%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i2457-75d5bdf971e7bf047cf150d39543b323d3a9a4a51479f08f0e9bf832a70b75ec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1514094648&rft_id=info:pmid/23720224&rfr_iscdi=true |